DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,074 filers reported holding DANAHER CORPORATION in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,776,887 | -75.2% | 102,273 | -73.9% | 0.58% | -68.2% |
| Q4 2022 | $103,977,223 | -37.6% | 391,746 | -39.3% | 1.82% | -12.5% |
| Q3 2022 | $166,690,000 | +15.5% | 645,359 | +13.3% | 2.08% | +35.2% |
| Q2 2022 | $144,356,000 | +29.5% | 569,408 | +49.8% | 1.54% | +77.7% |
| Q1 2022 | $111,473,000 | +2743.0% | 380,028 | +1299.7% | 0.86% | +1957.1% |
| Q3 2019 | $3,921,000 | -95.4% | 27,150 | -97.3% | 0.04% | -83.1% |
| Q2 2015 | $85,590,000 | -32.1% | 1,000,000 | -32.0% | 0.25% | -26.8% |
| Q4 2014 | $126,123,000 | -32.2% | 1,471,500 | -39.9% | 0.34% | -37.0% |
| Q3 2014 | $186,006,000 | +306.4% | 2,448,100 | +321.1% | 0.54% | +292.7% |
| Q2 2014 | $45,766,000 | +70.8% | 581,300 | +62.7% | 0.14% | +55.7% |
| Q1 2014 | $26,801,000 | -54.9% | 357,343 | -53.6% | 0.09% | -42.1% |
| Q4 2013 | $59,441,000 | -5.2% | 769,959 | -14.9% | 0.15% | -14.6% |
| Q3 2013 | $62,728,000 | +21.5% | 904,900 | +11.0% | 0.18% | +9.9% |
| Q2 2013 | $51,615,000 | – | 815,397 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |